Chronic treatment with Hsp90 inhibitors in obese or diabetic mouse models activates the Hsf1–Hsp70 stress pathway, leading to improved glucose control, reversal of hyperglycemia, and enhanced insulin sensitivity [235,238]. The gene discussed is INS; the disease is Hyperglycemia.